Health

Moderna’s Cancer Vaccine: A Triumph of Algorithm and Immunology

Updated 2026-08-27 08:40 UTC 1 source Positive

A personalized cancer vaccine developed by Moderna and Merck has shown promise, potentially revolutionizing immunotherapy. The success may also be attributed to an advanced algorithm.

Coverage timeline — 1 article

STAT News

STAT+: The mystery of Moderna’s magic algorithm

A personalized cancer vaccine developed by Moderna and Merck may be a triumph of immunology and cancer biology. It might also be the triumph of an algorithm.

2026-08-27 08:30 UTC